AH 9700
Alternative Names: AH-9700Latest Information Update: 28 May 2001
At a glance
- Originator Dainippon Pharmaceutical
- Class
- Mechanism of Action Muscarinic receptor antagonists; Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pollakisuria; Urinary incontinence
Most Recent Events
- 28 May 2001 Discontinued-Preclinical for Pollakisuria in Japan (Unknown route)
- 28 May 2001 Discontinued-Preclinical for Urinary incontinence in Japan (Unknown route)
- 27 Aug 1998 Preclinical development for Pollakisuria in Japan (Unknown route)